Background: The rapid development of the elderly population in the world has been a challenge for the world of medicine in the 21st century. The increase in this amount is due to the increasing problems of aging, such as metabolic syndrome and decreased muscle mass (sarcopenia). Both of these circumstances together have clinical consequences such as hypertension, stroke, diabetes mellitus, impaired mobility, even mortality. This study was conducted to determine whether there is a relationship between sarcopenia and the metabolic syndrome in the elderly.
Methods: This research was a descriptive-analytic study using cross sectional design. The study was conducted in July 2016 until January 2017 at Pusat Santunan Keluarga, West Jakarta with a total of 161 research subjects that consists of senior citizens over 60 years. Abdominal circumference, blood pressure, fasting blood glucose, HDL, and triglycerides were taken and categorized based on the NCEP ATP III criteria to define metabolic syndrome among the subjects. Sarcopenia was measured by means of bio-impedance analysis (BIA), handgrip dynamometer, and stopwatch. Data analysis was performed by using Chi Square test with 95 % of confidence intervals (a=0,05).
Results: The percentage of elderly in Pusat Santunan Keluarga, West Jakarta who had metabolic syndrome, moderate sarcopenia, and severe sarcopenia respectively were 57.1%, 37.3% and 28.6%. The data analysis showed a significant association between sarcopenia with metabolic syndrome (p=0,029), sarcopenia with abdominal obesity (p=0,007), sarcopenia with hypertension (p=0,03), and sarcopenia with hyperglycemia (p=0,045). However, there’s no significant association found between sarcopenia with atherogenic dyslipidemia (p=0,459).
Conclusions: This study found a significant relationship between sarcopenia with metabolic syndrome, abdominal obesity, hypertension, and hyperglycemia. However, there’s an absence of a significant relationship between sarcopenia with atherogenic dyslipidemia in this study. |